Downregulation of PHLDA1 was associated with poor prognosis, more advanced clinical stage, and decreased overall survival (OS), as shown by the analysis of Kaplan–Meier curves in breast cancer patients. The gene discussed is PHLDA1; the disease is breast cancer.